Caas Capital Management LP Cytek Biosciences, Inc. Transaction History

Caas Capital Management LP

  • $836 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$9.71 - $15.86 $162,506 - $265,432
16,736 New
16,736 $170,000
Q4 2021

Feb 14, 2022
SELL
$16.14 - $25.04 $1.61 Million - $2.5 Million
-100,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$17.52 - $27.93 $1.75 Million - $2.79 Million
100,000 New
100,000 $2.14 Million

Others Institutions Holding CTKB

# of Institutions
133
Shares Held
71.6M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $918M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email